Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schmidt-Wolf

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Mycoses|February 19, 2000
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsulesA Glasmacher, C Hahn, E Molitor, et al.
Leukemia & Lymphoma|December 30, 1998
Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemiaM Müller, C Scheffold, P Lefterova, et al.
Deutsche Medizinische Wochenschrift (1946)|March 3, 2006
[Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials]C Lamberti, S Lundin, M Bogdanow, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12D Flieger, U Spengler, I Beier, et al.
Mycoses|October 28, 1999
Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemiaA Glasmacher, C Hahn, E Molitor, et al.
Transfusion|January 1, 1992
In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservationI G Schmidt-Wolf, M Aihara, R S Negrin, et al.
Digestion|September 2, 2003
Requirements for adeno-associated virus-derived non-viral vectors to achieve stable and site-specific integration of plasmid DNA in liver carcinoma cellsRobin Steigerwald, Christian Rabe, Volker Schmitz, et al.
Journal of Immunological Methods|December 20, 1989
Lymphokine-activated killer cell activity after cryopreservationI G Schmidt-Wolf, M Aihara, R S Negrin, et al.
Cytokine|September 8, 2000
Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulationB Zoll, P Lefterova, O Ebert, et al.
European Journal of Immunology|January 1, 1997
Human T lymphocytes bind to germinal centers of human tonsils via integrin alpha4/VCAM-1 and LFA-1/ICAM-1 and -2F Schriever, D Korinth, A Salahi, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Mycoses|February 19, 2000
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsulesA Glasmacher, C Hahn, E Molitor, et al.
Leukemia & Lymphoma|December 30, 1998
Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemiaM Müller, C Scheffold, P Lefterova, et al.
Deutsche Medizinische Wochenschrift (1946)|March 3, 2006
[Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials]C Lamberti, S Lundin, M Bogdanow, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12D Flieger, U Spengler, I Beier, et al.
Mycoses|October 28, 1999
Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemiaA Glasmacher, C Hahn, E Molitor, et al.
Transfusion|January 1, 1992
In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservationI G Schmidt-Wolf, M Aihara, R S Negrin, et al.
Digestion|September 2, 2003
Requirements for adeno-associated virus-derived non-viral vectors to achieve stable and site-specific integration of plasmid DNA in liver carcinoma cellsRobin Steigerwald, Christian Rabe, Volker Schmitz, et al.
Journal of Immunological Methods|December 20, 1989
Lymphokine-activated killer cell activity after cryopreservationI G Schmidt-Wolf, M Aihara, R S Negrin, et al.
Cytokine|September 8, 2000
Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulationB Zoll, P Lefterova, O Ebert, et al.
European Journal of Immunology|January 1, 1997
Human T lymphocytes bind to germinal centers of human tonsils via integrin alpha4/VCAM-1 and LFA-1/ICAM-1 and -2F Schriever, D Korinth, A Salahi, et al.
Pageof 8